2024 annual financial data
iBio 2024 Operating margin
Direct answer
Operating margin was -7,392.89%.
Operating income was -16,634,000 USD and net income was -24,907,000 USD.
Operating cash flow was -18,554,000 USD.
Get free iBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 225,000 USD
- Operating income
- -16,634,000 USD
- Net income
- -24,907,000 USD
- Operating cash flow
- -18,554,000 USD